Related Experiment Video
Updated: May 12, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Differentiated thyroid carcinoma: defining new paradigms for postoperative management
Cosimo Durante1, Giuseppe Costante, Sebastiano Filetti
1Department of Internal Medicine and Medical Specialties, University of Rome Sapienza, Viale del Policlinico 155, Rome, Italy.
Endocrine-Related Cancer
|April 11, 2013
Summary
Differentiated thyroid cancers (DTCs) are now smaller and found incidentally. Management strategies are evolving to better suit current DTC demographics and improved diagnostic tools for personalized patient care.
Area of Science:
- Endocrinology
- Oncology
- Nuclear Medicine
Background:
- Differentiated thyroid cancers (DTCs) demographics have shifted significantly since the 1990s.
- Current DTCs are often small, asymptomatic, and detected incidentally, unlike earlier presentations.
- Advancements in diagnostic and monitoring tools necessitate revised management approaches.
Purpose of the Study:
- To review current issues in differentiated thyroid cancer (DTC) management.
- To discuss risk stratification for recurrence and mortality.
- To evaluate indications and efficacy of various follow-up strategies for DTC.
Main Methods:
- Review of current literature on DTC diagnosis, treatment, and monitoring.
- Analysis of risk assessment for disease recurrence and cancer-related death.
- Evaluation of follow-up tools including serum thyroglobulin, neck ultrasound, PET, and radioiodine scintigraphy.
Main Results:
- DTCs are increasingly detected incidentally and are often less aggressive.
- Risk stratification is crucial for tailoring treatment and follow-up intensity.
- Various diagnostic tools have specific roles in monitoring DTC patients.
Conclusions:
- Individualized, risk-tailored management algorithms are essential for current DTC patients.
- Optimizing the use of diagnostic tools and therapeutic interventions ensures cost-effective care.
- Revised paradigms are needed to address the changing landscape of differentiated thyroid cancer.
